ISSN:
1573-0646
Keywords:
fludarabine phosphate
;
2-fluoro-ara-AMP
;
phase II
;
melanoma
Source:
Springer Online Journal Archives 1860-2000
Topics:
Chemistry and Pharmacology
,
Medicine
Notes:
Abstract Twenty-seven evaluable patients with advanced malignant melanoma received fludarabine phosphate in a daily × 5 injection. Initial dosing was based on the presence of previous radiation therapy. There was no response seen in these patients despite appropriate dose escalation. Myelosuppression occurred without significant sequelae.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00194559
Permalink